Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-02-06

Clinical Trial Update: Selonsertib in Combination With Prednisolone Versus Prednisolone Alone in Participants With Severe Alcoholic Hepatitis (AH) [Phase 2]

View source ↗

Summary

Phase 2 trial comparing Selonsertib plus prednisolone versus prednisolone alone in severe alcoholic hepatitis has completed, with results posted in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Prednisolone (Prednisolone)
  • Selonsertib (selonsertib)

Snippet

Sponsor: Gilead Sciences | Conditions: Alcoholic Hepatitis (AH) | Phase 2 | Status: COMPLETED | Results posted: 2019-02-06